TP53 and acute myeloid leukemia: The findings reveal allele-specific loss of MDM2 in TP53-mutant AML, indicating that MDM2 haploinsufficiency collaborates with mutant TP5P3 to promote myeloid-biased hematopoiesis and enhance AML predisposition, independent of p53's regulatory functions.